Recorded device evidence

FASTEP S10 HCG SERUM/URINE COMBO TEST (K132834): indications, design and recorded evidence

The acquired K132834 file contains product-specific indications and users, design and operating principle, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 2 selected decisions under primary code JHI. 2 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K132834 ↗ · this pageFASTEP S10 HCG SERUM/URINE COMBO TEST2013-09-10 → 2014-01-09121Traditional
K262299 ↗Instant-View® hCG Combo II Cassette Test2026-07-07 → 2026-09-2277Traditional
K241919 ↗Innovita HCG Pregnancy Rapid Combo Test2024-07-01 → 2024-08-0232Traditional
K203272 ↗Alltest Pregnancy Rapid Combo Test Cassette2020-11-06 → 2022-01-31451Traditional
K172322 ↗Atellica IM Total hCG (ThCG)2017-08-01 → 2018-03-29240Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K132834 · PDF page 11 ↗ Source 2

The      Fastep         SI 10         hCG     Serum/Urine         Combo         Test  is a rapid     visual        immunoassay         for  the
qualitative,  presumptive    detection      of human   chorionic    gonadotropin        in   human        urine     or
serum       specimens.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K132834 · PDF page 1 ↗ Source 3

Fastep             SIO               hCG              Serum/Urine               Combo                Test             measures               the            presence              of        the           hormone                Human
                                Chorionic                   Gonadotrophin                         (HCG)                       in                     human                        urine                    or                    serum                      for                    the                    early                  detection                         of
                                pregnancy.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K132834 · PDF page 2 ↗ Source 4

a. Precision/Reproducibility/Cut-Off                 Value
                                                                   Negative                    serum                        specimens                   were                  spiked                   with                  varying                  hCG               (commercially                        available                    and
                                                                   traceable          to      the       4th             WHO        international              Standard)           concentrations.                                           The        spiked           samples            were
                                                                   measured              in                   10          replicates                using               3   different             lots                 for            each             format.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK132834 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryFASTEP S10 HCG SERUM/URINE COMBO TEST [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantPolymed Therapeutics, Inc. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeJHI [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2014-01-09 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2013-09-10 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[27546] · record 9d68eb61a55979de132b6f3140dd847fc3e7f3c36385fc3bf20424b69f4c7a7b
  • [5] Complete results array / fda-decision-context:K132834 · record whole dataset partition

FDA 510(k) summary — K132834 ↗

Fri, 07 Feb 2014 17:53:01 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot b85e2a3e671e5adc7b6c3b1917b604eb4f851208904a3f51e20a9fd0f0b32b42

  • [2] PDF page 11 · record 36da49bf1820c4d29cf1cd33d1813e6f6597018ffb6166d91aefed9f8999e367
  • [3] PDF page 1 · record 28d0a15a57e73e1c02e0e281c7181b90cd398f2b44ca902acff57f893b1a6518
  • [4] PDF page 2 · record 919c889971cf62bea2b87827d66aeda41046d8eeb9caca030049dfc70d67c693

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services